Introduction The potential impact of targeting different components of an adverse lipid profile
in populations with multiple cardiovascular risk factors is not completely clear. This study …

Objective The aim of this study was to evaluate and compare the role of lipid markers
including total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol …

Background: Dyslipidemia is one of the modifiable risk factors for cardiovascular diseases
(CVD). Identifying subjects with lipid abnormality facilitates preventative interventions …

Introduction Dyslipidemia may be defined as increased levels of serum total cholesterol
(TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), or a decreased serum …

Objective: In this work, we assessed the status and management of blood lipids in a sample
of cardiovascular disease free adult men and women from Greece. We also evaluated the …

Background To examine the association between potentially modifiable risk factors with
cardiovascular disease (CVD) and all-cause mortality and to quantify their population …

The 5-year incidence of cardiovascular disease (CVD) and its determinants, in a sample of
men and women from Greece, was evaluated. From May 2001 to December 2002, 1514 …

Background Atherogenic dyslipidemia is associated with poor cardiovascular outcomes, yet
markers of this condition are often ignored in clinical practice. Here, we address a clear …

Cardiovascular disease is one of the most important public health problems in developed
countries. We have studied the epidemiology of the following cardiovascular disease risk …

Aim: Primordial prevention is essential for reaching cardiovascular (CV) health. This is
defined by seven health metrics identified by the American Heart Association. Aim of the …